Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes

New England Journal of Medicine

Volumn 376, Issue 7, 2017, Pages 641-651

  Schauer, Philip R ^a   Bhatt, Deepak L ^b   Kirwan, John P ^a   Wolski, Kathy ^a   Aminian, Ali ^a   Brethauer, Stacy A ^a   Navaneethan, Sankar D ^c   Singh, Rishi P ^a   Pothier, Claire E ^a   Nissen, Steven E ^a   Kashyap, Sangeeta R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; AMNESIA; ANEMIA; ARTICLE; BARIATRIC SURGERY; BLEEDING; BODY MASS; CEREBROVASCULAR ACCIDENT; CHOLELITHIASIS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DEHYDRATION; DEPRESSION; DISEASE DURATION; DRUG TREATMENT FAILURE; DUMPING SYNDROME; FEMALE; FOOT ULCER; FRACTURE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GLYCEMIC CONTROL; HEART INFARCTION; HERNIA; HUMAN; HYPERGLYCEMIA; HYPOALBUMINEMIA; HYPOGLYCEMIA; INTENTION TO TREAT ANALYSIS; INTESTINE OBSTRUCTION; KETOACIDOSIS; KIDNEY DISEASE; LIMB FRACTURE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MORTALITY RATE; NEPHROLITHIASIS; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PNEUMONIA; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; ROUX-EN-Y GASTRIC BYPASS; SEPSIS; SEX DIFFERENCE; SLEEVE GASTRECTOMY; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; ULCER; URETER STONE; URINE INCONTINENCE; WEIGHT GAIN; WEIGHT REDUCTION; WOUND INFECTION; ANALYSIS; BLOOD; COMPARATIVE STUDY; COMPLICATION; DIABETES MELLITUS, TYPE 2; GASTRECTOMY; GASTRIC BYPASS SURGERY; GLUCOSE BLOOD LEVEL; MIDDLE AGED; MULTIMODALITY CANCER THERAPY;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; GASTRIC BYPASS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; OBESITY; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 85013391679     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1600869     Document Type: Article

References (24)

1. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339-52.
2. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-85.
3. Vest AR, Heneghan HM, Agarwal S, Schauer PR, Young JB. Bariatric surgery and cardiovascular outcomes: A systematic review. Heart 2012; 98: 1763-77.
4. Sjostrom L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-Term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 2014; 311: 2297-304.
5. Arterburn DE, Olsen MK, Smith VA, et al. Association between bariatric surgery and long-Term survival. JAMA 2015; 313: 62-70.
6. Brethauer SA, Aminian A, Romero-Talamas H, et al. Can diabetes be surgically cured? Long-Term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg 2013; 258: 628-37.
7. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: A randomized controlled trial. JAMA 2008; 299: 316-23.
8. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366: 1567-76.
9. Kashyap SR, Bhatt DL, Wolski K, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: Analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care 2013; 36: 2175-82.
10. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 3-year outcomes. N Engl J Med 2014; 370: 2002-13.
11. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow- up of an open-label, single-centre, randomised controlled trial. Lancet 2015; 386: 964-73.
12. Ikramuddin S, Billington CJ, Lee WJ, et al. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol 2015; 3: 413-22.
13. Liang Z, Wu Q, Chen B, Yu P, Zhao H, Ouyang X. Effect of laparoscopic Rouxen- Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: A randomized controlled trial. Diabetes Res Clin Pract 2013; 101: 50-6.
14. Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg 2014; 149: 716-26.
15. Courcoulas AP, Belle SH, Neiberg RH, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: A randomized clinical trial. JAMA Surg 2015; 150: 931-40.
16. Wentworth JM, Playfair J, Laurie C, et al. Multidisciplinary diabetes care with and without bariatric surgery in overweight people: A randomised controlled trial. Lancet Diabetes Endocrinol 2014; 2: 545-52.
17. Parikh M, Chung M, Sheth S, et al. Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. Ann Surg 2014; 260: 617-24.
18. Ding SA, Simonson DC, Wewalka M, et al. Adjustable gastric band surgery or medical management in patients with type 2 diabetes: A randomized clinical trial. J Clin Endocrinol Metab 2015; 100: 2546-56.
19. Cummings DE, Arterburn DE, Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: The CROSSROADS randomised controlled trial. Diabetologia 2016; 59: 945-53.
20. Kashyap SR, Bhatt DL, Schauer PR, STAMPEDE Investigators. Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: Rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE). Diabetes Obes Metab 2010; 12: 452-4.
21. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ 1993; 2: 217-27.
22. Singh RP, Gans R, Kashyap SR, et al. Effect of bariatric surgery versus intensive medical management on diabetic ophthalmic outcomes. Diabetes Care 2015; 38(3): E32-e33.
23. The Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1998; 116: 874-86.
24. Kolandaivelu K, Leiden BB, O'Gara PT, Bhatt DL. Non-Adherence to cardiovascular medications. Eur Heart J 2014; 35: 3267-76.